A diamond in the rough $, page-66

I wouldn't have imagined that, with a normal company, finding two new directors would take this long.

But looking at the announcement by ASX on 7th November I see that the potential for prolonged delay is not just the finding of two new directors. They have to be independent and meet with the approval of the ASX. That could be a time consuming job for a company with the internalised mindset of MED.

It's worse than that. The augmented MED Board has to work with these two new independent directors to "review and revisit the queries and answers to the ASX from the 9,17, and 29 October 2018."

The mind boggles.